Oncolytics Biotech Inc
(MENAFN- Baystreet) 09:41 AM EST - Oncolytics Biotech Inc : Announces discussion by field-leading key opinion leaders during a recent event hosted by H.C. Wainwright. Martine Piccart, M.D., Ph.D., an Honorary Professor of Oncology at the Université Libre de Bruxelles and Scientific Director of Oncology at the Institut Jules Bordet, in Brussels, Belgium, offered a detailed overview of the HR+/HER2- metastatic breast cancer landscape and emphasized the need for new treatment innovations, such as pelareorep, that work to activate the immune system to recognize and kill cancer. Oncolytics Biotech Inc
shares T are trading unchanged at $0.74.
Full Press Release:
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research
- Brazil Edtech Market Size, Share, Trends, And Forecast 2025-2033
- Vietnam Vegan Food Market Size, Share, Trends And Report 2025-2033
- Cryptogames Introduces Platform Enhancements Including Affiliate Program Changes
- Accounting And Bookkeeping Service Business Plan 2025: How To Start, Operate, And Grow
- USDT0 And Xaut0 Are Now Live On Polygon
- Global Open Banking Market 20252033: Services, Deployment & Distribution Trends
More Story
Comments
No comment